Constarium
← Search

Omics · study · 2026

Transcriptomic profiling of CT26 tumor-bearing mice treated with novel HDAC inhibitor GNTbm-38

Listed in NCBI GEO

Histone deacetylase inhibitors (HDACis) represent a promising therapeutic strategy in cancer treatment.

Description

In this study, we evaluated the therapeutic efficacy and molecular mechanisms of GNTbm-38, a novel HDAC inhibitor, using a syngeneic CT26 colon carcinoma tumor-bearing mouse model. BALB/c mice bearing subcutaneous CT26 tumors were treated with vehicle control or GNTbm-38.

Bulk RNA-sequencing was performed on tumor tissues to characterize transcriptomic alterations induced by GNTbm-38. This dataset provides comprehensive gene expression profiles to elucidate the antitumor and immunomodulatory pathways regulated by GNTbm-38 in colorectal cancer.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 75%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE34771211 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (75%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:10090source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title